What are the differential diagnoses and alternative approaches for a patient with suspected atypical infection, pulmonary embolism, and pulmonary edema secondary to heart failure with preserved ejection fraction, presenting with hypoxemia, altered sensorium, hypotension, impaired renal function, mildly elevated liver function tests, and thrombocytopenia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differential Diagnoses and Alternative Approaches

Your Current Working Diagnosis is Reasonable but Incomplete

Your suspicion of atypical infection, pulmonary embolism, and HFpEF-related pulmonary edema is appropriate, but you must systematically exclude several critical life-threatening conditions and consider additional diagnoses that fit this presentation. 1

Critical Differential Diagnoses to Consider

Immediately Life-Threatening Conditions

Septic shock with multiorgan dysfunction should be at the top of your differential given the combination of altered sensorium, hypotension (SBP 100 mmHg), thrombocytopenia, elevated creatinine, and mildly elevated LFTs. 1 The thrombocytopenia with organ dysfunction suggests possible:

  • Sepsis-induced DIC - thrombocytopenia with multiorgan involvement is classic 1
  • Bacterial pneumonia with sepsis - already on levofloxacin and cefoperazone-sulbactam, but may need broader coverage 1

Cardiogenic shock must be differentiated from other shock states. With SBP 100/80 mmHg and altered sensorium, this patient may be in early cardiogenic shock, which the ESC defines as evidence of tissue hypoperfusion with SBP <90 mmHg or mean arterial pressure drop >30 mmHg. 1 Your bedside echocardiography should specifically assess:

  • Left ventricular ejection fraction and wall motion abnormalities 1
  • Right ventricular size and function (RV/LV diameter ratio >0.6 or area >1.0 suggests PE) 1
  • McConnell sign (RV free wall hypokinesia with apical sparing) - highly specific for acute PE 1
  • Pericardial effusion with tamponade features (RA collapse, RV diastolic collapse, IVC plethora) 1

Thrombotic Microangiopathy Syndromes

The combination of thrombocytopenia, acute kidney injury, altered mental status, and possible hemolysis should trigger consideration of:

  • Thrombotic thrombocytopenic purpura (TTP) - check ADAMTS13 activity, peripheral smear for schistocytes, LDH, indirect bilirubin 2
  • Atypical hemolytic uremic syndrome (aHUS) - complement-mediated, can cause acute heart failure and multiorgan dysfunction 2
  • Disseminated intravascular coagulation (DIC) - check PT/INR, fibrinogen, D-dimer (though D-dimer will be elevated in PE as well) 1

Cardiac-Specific Differentials

Acute coronary syndrome with cardiogenic shock - altered sensorium can be the presenting feature of extensive MI. 1 You need:

  • Serial troponins (not just one value) 1
  • ECG looking for STEMI, new LBBB, or dynamic ST-T changes 1

Acute valvular dysfunction - particularly acute mitral or aortic regurgitation from endocarditis (given fever/infection suspicion). 1 Echocardiography should specifically assess:

  • Valve morphology and function 1
  • Vegetations 1

Acute myocarditis - can present with heart failure, arrhythmias, and elevated troponins. 1

Pulmonary-Specific Differentials

Acute respiratory distress syndrome (ARDS) - SpO2 74% with bilateral infiltrates could represent ARDS from sepsis, pneumonia, or aspiration rather than pure cardiogenic pulmonary edema. 1

Massive pulmonary embolism - your prophylactic dose of enoxaparin is insufficient if PE is confirmed. The ESC guidelines state that in suspected high-risk PE with hypotension, bedside echocardiography showing RV dysfunction is sufficient to prompt immediate therapeutic anticoagulation or even thrombolysis. 1

Metabolic/Toxic Causes

Severe metabolic derangements contributing to altered sensorium:

  • Uremic encephalopathy (creatinine 1.5 may underestimate severity if acute) 1
  • Hepatic encephalopathy (mildly elevated LFTs - need ammonia level) 1
  • Hypoxic encephalopathy from prolonged hypoxemia 1

Critical Diagnostic Gaps in Your Current Approach

Immediate Bedside Tests You Should Perform Now

Bedside transthoracic echocardiography is mandatory in this hemodynamically unstable patient. The ESC guidelines explicitly state this is the most useful initial test when PE is suspected with shock/hypotension. 1 Look for:

  • RV dysfunction (confirms high-risk PE if present) 1
  • LV systolic function (confirms or refutes HFpEF diagnosis) 1
  • Pericardial effusion/tamponade 1
  • Right heart thrombi (rare but diagnostic for PE) 1

Arterial blood gas - not just pulse oximetry. You need: 1

  • PaO2 to calculate A-a gradient 1
  • PaCO2 to assess ventilation 1
  • pH and lactate to assess tissue perfusion and shock state 1

Laboratory Tests You Must Add

Complete blood count with peripheral smear - to assess for: 2

  • Schistocytes (TTP, aHUS, DIC) 2
  • Severity of thrombocytopenia and trend 2
  • White blood cell count and differential (left shift suggests bacterial infection) 1

Coagulation studies beyond D-dimer: 1

  • PT/INR, aPTT, fibrinogen (to assess for DIC) 1
  • If thrombocytopenia is severe, consider ADAMTS13 activity 2

Hemolysis workup: 2

  • LDH (elevated in hemolysis, PE, and tissue ischemia) 2
  • Indirect bilirubin 2
  • Haptoglobin 2

Troponin - serial measurements, not just one value. Elevated troponin occurs in: 1

  • Acute MI 1
  • Acute PE (indicates RV strain) 1
  • Myocarditis 1
  • Severe sepsis 1

Blood cultures - before escalating antibiotics, given concern for sepsis. 1

Imaging Beyond What You've Ordered

Chest X-ray interpretation must be systematic: 1

  • Cardiomegaly suggests chronic heart failure 1
  • Bilateral infiltrates: distinguish cardiogenic pulmonary edema (bat-wing, Kerley B lines, pleural effusions) from ARDS (peripheral, patchy) 1
  • Westermark sign or Hampton's hump (rare but specific for PE) 1

CT pulmonary angiography (CTPA) is the definitive test for PE but should NOT be performed until the patient is stabilized. 1 The ESC guidelines state that in hemodynamically unstable patients, echocardiographic evidence of RV dysfunction is sufficient to start treatment, with CTPA performed once stabilized. 1

Lower extremity compression ultrasonography - finding proximal DVT is sufficient to warrant full anticoagulation for PE without further testing. 1 This can be done at bedside and is particularly useful if CTPA is not immediately available or if renal function precludes contrast. 1

How This Case Should Have Been Approached Differently

Initial Assessment Algorithm

Step 1: Immediate stabilization takes precedence over diagnosis 1

  • Oxygen therapy - target SpO2 >90%, but avoid excessive oxygen (causes vasoconstriction and reduced cardiac output in non-hypoxemic patients). 1 With SpO2 74%, this patient needs high-flow oxygen or non-invasive ventilation immediately. 1
  • Hemodynamic support - with SBP 100 mmHg and altered sensorium, this patient has inadequate perfusion. Consider vasopressors if fluid status is adequate. 1
  • Continuous monitoring - ECG, blood pressure, SpO2, urine output. 1

Step 2: Parallel diagnostic and therapeutic approach 1

The British Thoracic Society and ESC guidelines emphasize that in suspected PE with high clinical probability, heparin should be started before diagnosis is confirmed. 1 However, your use of prophylactic-dose enoxaparin is inadequate:

  • If PE is suspected with hemodynamic instability, therapeutic anticoagulation is indicated immediately unless contraindicated. 1
  • Prophylactic dosing will not treat PE - you need therapeutic dosing (enoxaparin 1 mg/kg SC q12h or 1.5 mg/kg SC daily, or unfractionated heparin infusion). 1

Step 3: Bedside echocardiography BEFORE advanced imaging 1

In hemodynamically unstable patients, the ESC guidelines explicitly recommend bedside TTE as the first imaging test. 1 This will:

  • Confirm or refute RV dysfunction (present in high-risk PE) 1
  • Assess LV function (your HFpEF hypothesis requires EF ≥50%) 1
  • Exclude tamponade, acute valvular dysfunction, severe LV dysfunction 1

Step 4: Risk stratification for PE 1

If PE is confirmed or highly suspected:

  • High-risk PE (with shock/hypotension): Consider thrombolysis - the ESC guidelines state thrombolytic therapy is indicated in hemodynamically unstable patients. 1
  • Intermediate-risk PE (RV dysfunction but stable BP): Therapeutic anticoagulation, close monitoring, consider escalation. 1

Antibiotic Coverage Reassessment

Levofloxacin + cefoperazone-sulbactam is reasonable empiric coverage for community-acquired pneumonia with atypical organisms, but consider: 1

  • Broadening coverage if septic shock - may need vancomycin for MRSA, especially if healthcare-associated. 1
  • Checking procalcitonin - helps differentiate bacterial infection from other causes of SIRS. 1

Fluid Management Controversy

Your plan for "negative balance" and furosemide is appropriate IF this is cardiogenic pulmonary edema, but potentially harmful if this is septic shock or hypovolemia. 1

The ESC Heart Failure guidelines state: 1

  • Diuretics provide rapid symptomatic relief in pulmonary edema through venodilation and subsequent fluid removal. 1
  • However, in cardiogenic shock or hypotension, diuretics can worsen perfusion. 1

Your approach should be: 1

  • If pulmonary edema with adequate BP (SBP >100 mmHg): IV furosemide is appropriate. 1
  • If hypotension (SBP <90 mmHg or signs of hypoperfusion): Hold diuretics, consider inotropes/vasopressors, and reassess volume status with echocardiography (IVC diameter, LV filling). 1

BNP/NT-proBNP Interpretation Caveats

BNP/NT-proBNP is useful but has limitations in this context: 1

  • Elevated in: Heart failure, PE (RV strain), renal dysfunction, sepsis, atrial fibrillation. 1
  • The ESC guidelines state normal D-dimer excludes PE (high sensitivity), but elevated D-dimer is non-specific. 1
  • In hospitalized patients, D-dimer has limited utility due to high false-positive rate. 1

Specific Recommendations for This Patient

Immediate Actions (Next 1-2 Hours)

  1. Upgrade to therapeutic anticoagulation if no contraindications - either unfractionated heparin infusion (easier to reverse if needed) or therapeutic enoxaparin. 1

  2. Bedside echocardiography - assess RV function, LV function, valves, pericardium. 1

  3. Arterial blood gas - assess oxygenation, ventilation, acid-base status, lactate. 1

  4. Peripheral smear, LDH, haptoglobin, indirect bilirubin - rule out thrombotic microangiopathy. 2

  5. Serial troponins - assess for ACS or RV strain from PE. 1

  6. Blood cultures - before escalating antibiotics. 1

  7. Reassess hemodynamics - if SBP drops below 90 mmHg or signs of worsening perfusion, consider ICU transfer, vasopressors, and hold diuretics. 1

Diagnostic Algorithm Based on Echo Findings

If echo shows RV dysfunction (RV dilation, RV hypokinesia, McConnell sign): 1

  • High suspicion for PE - continue therapeutic anticoagulation. 1
  • If hemodynamically unstable: Consider thrombolysis (alteplase 100 mg over 2 hours). 1
  • Perform CTPA when stabilized for definitive diagnosis. 1
  • Lower extremity ultrasound - if positive for DVT, no need for CTPA. 1

If echo shows severe LV systolic dysfunction (EF <40%): 1

  • This is NOT HFpEF - this is acute decompensated systolic heart failure or cardiogenic shock. 1
  • Assess for ACS - urgent cardiology consultation, consider coronary angiography. 1
  • Diuretics appropriate if SBP adequate - IV furosemide bolus or infusion. 1
  • If hypotensive: Inotropes (dobutamine) ± vasopressors (norepinephrine). 1

If echo shows preserved EF (≥50%) with diastolic dysfunction: 1

  • Consistent with HFpEF - but must exclude HFpEF mimics. 1
  • Check for: Infiltrative cardiomyopathy (increased wall thickness, "sparkling" myocardium suggests amyloidosis), hypertrophic cardiomyopathy, pericardial disease. 1
  • Diuretics for pulmonary edema - cautious dosing as HFpEF patients are preload-dependent. 1

If echo shows pericardial effusion with tamponade physiology: 1

  • Urgent pericardiocentesis - this is a life-threatening emergency. 1

Common Pitfalls to Avoid

Pitfall 1: Using prophylactic-dose anticoagulation when therapeutic dosing is indicated. 1 If PE is suspected with high clinical probability, the British Thoracic Society and ESC guidelines recommend starting therapeutic heparin before diagnosis is confirmed. 1

Pitfall 2: Ordering CTPA before stabilizing the patient. 1 In hemodynamically unstable patients, bedside echo is the first test, and treatment decisions can be made based on echo findings alone. 1

Pitfall 3: Aggressive diuresis in a hypotensive patient. 1 With SBP 100 mmHg, this patient is borderline hypotensive. Diuretics can worsen perfusion and precipitate frank shock. 1

Pitfall 4: Assuming thrombocytopenia is simply due to infection. 2 The combination of thrombocytopenia, AKI, and altered mental status should trigger consideration of TTP/aHUS/DIC, which require specific urgent treatments. 2

Pitfall 5: Interpreting D-dimer in isolation. 1 D-dimer is useful to exclude PE when negative, but elevated D-dimer is non-specific (elevated in infection, renal failure, heart failure, DIC). 1 In hospitalized patients, D-dimer has limited utility. 1

Pitfall 6: Failing to consider non-cardiac causes of dyspnea and hypoxemia. 1 The ACC guidelines emphasize that not every patient with dyspnea and preserved EF has HFpEF - consider renal failure, liver disease, chronic venous insufficiency, ARDS, pneumonia. 1

Pitfall 7: Delaying hypercoagulability workup inappropriately. 3 If PE is confirmed and the patient is young (<50 years) with unprovoked PE, genetic testing (Factor V Leiden, Prothrombin G20210A) can be done during anticoagulation, but functional assays (Protein C/S, Antithrombin III, lupus anticoagulant) should wait until after completing therapy. 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Laboratory Testing for Hypercoagulability in Patients with Bilateral PE on Apixaban

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.